George A. Pankey
Infectious Disease Research
Ochsner Clinic Foundation
New Orleans
LA 70121
USA
Name/email consistency: high
- In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia. Pankey, G.A., Ashcraft, D.S. Diagn. Microbiol. Infect. Dis. (2010)
- In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assay. Pankey, G.A., Ashcraft, D.S. Diagn. Microbiol. Infect. Dis. (2009)
- The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest and time-kill assay. Pankey, G.A., Ashcraft, D.S. Diagn. Microbiol. Infect. Dis. (2009)
- In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa. Pankey, G.A., Ashcraft, D.S. Antimicrob. Agents Chemother. (2005)
- Tigecycline. Pankey, G.A. J. Antimicrob. Chemother. (2005)
- In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Pankey, G., Ashcraft, D., Patel, N. Antimicrob. Agents Chemother. (2005)
- Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Pankey, G.A., Sabath, L.D. Clin. Infect. Dis. (2004)